Skip to Main Content

First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1046 in Subjects With Malignant Solid Tumors

Conditions

Lung | Phase I | Breast | Cervix

Phase I

What is the purpose of this trial?

The purpose of the trial is to evaluate the safety of GEN1046 in patients with malignant solid tumors

  • Trial with
    Genmab, Inc.
  • Start Date
    01/12/2020
  • End Date
    02/01/2022

For more information about this study, contact:

Ingrid Palma

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    05/29/2020
  • Study HIC
    #2000025194